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Abstract
Human co-infection with Plasmodium falciparum and helminths is ubiquitous throughout Africa,
although its public health significance remains a topic for which there are many unknowns. In this
review we have adopted an empirical approach to investigating the geography and epidemiology
of co-infection, and associations between patterns of co-infection and haemoglobin in different
age groups. Analysis highlights the extensive geographic overlap between P. falciparum and the
major human helminth infections in Africa, with the population at coincident risk of infection
greatest for hookworm. Age infection profiles indicate that school-age children are at the highest
risk of co-infection, and re-analysis of existing data suggests that co-infection with P. falciparum
and hookworm has an additive impact on hemoglobin, exacerbating anemia-related malarial
disease burden. We suggest that both school-age children and pregnant women – groups among
the highest risk of anemia - would benefit from an integrated approach to malaria and helminth
control.
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INTRODUCTION
Malaria poses an enormous public health burden and more than 75% of the global clinical
episodes due to Plasmodium falciparum each year are concentrated in Africa.1 Across the
continent, a number of helminth species share the same spatial extents as P. falciparum. The
most ubiquitous of these are the soil-transmitted helminths (STH: Ascaris lumbricoides,
Trichuris trichiura, and hookworms), which infect more than a third of the continent's
population infected at any one time.2 The schistosomes, Schistosoma haematobium and S.
mansoni, are also endemic throughout the continent, but generally have a much more focal
distribution than STH species.3 In Africa, the overall prevalence of Wuchereria bancrofti,
which causes lymphatic filariasis (LF), is low4, but the disease continues to be of
considerable local importance in endemic foci. Finally, onchocerciasis, caused by
Onchocerca volvulus, is widely distributed throughout the continent.5
Spatial congruence of both P. falciparum and different helminths remains poorly defined.
Preliminary analyses however, suggest that as many as a quarter of African schoolchildren
may be coincidentally at-risk of P. falciparum and hookworm.6 This spatial coincidence of
risk between these two parasite populations would suggest that co-infection is extremely
common although the public health significance of polyparasitic infection remains a topic
for which there are many unknowns. For example, although we know that helminth
infections elicit a potent, highly polarized immune responses characterized by elevated T-
helper cell type 2 (Th2) cytokine and Immunoglobulin(Ig)E production,7 it is unclear
whether these responses may modulate human immune responses to malaria and therefore
alter susceptibility to clinical disease.8 Similarly, although malaria and helminth infections
are known aetiological factors in tropical anemia,9-11 the extent to which their combined
presence might interact to further enhance the risk of anaemia is poorly understood. Finally,
although the relevance of an integrated, non-disease specific approach to controlling
childhood anemia is an increasingly recognized strategy12, following a general move
toward integrated disease control programmes,13, 14 the public health evidence base for
combined malaria and helminth control requires better definition.
Two recent reviews have focused on either the epidemiological 15 or immunological 8
evidence on plasmodium-helminth interactions. In contrast, this paper quantitatively
investigates the geography and epidemiology of co-infection and its potential impact on
anemia, as well as the exploring the wider implications of co-infection for disease control in
Africa.
PREDICTED PATTERNS OF CO-DISTRIBUTION
The large-scale distributions of parasitic diseases are governed by a number of
environmental factors, principally temperature and humidity. We have previously used a
combination of temperature, rainfall and altitude to predict the continental distribution of
each of the major STH species.2 These models suggest that the prevalence of A.
lumbricoides and T. trichiura is greatest in equatorial, central and west Africa, eastern
Madagascar and southeast Africa, whereas hookworm is more widely distributed across the
continent. Other workers have used climate-driven Fuzzy logic models to define the
suitability for stable malaria transmission across Africa16, and previous estimations 17, 18
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classify transmission conditions into four classes: zero risk, marginal risk, acute seasonal
risk and stable risk. Combining these different spatial models has previously allowed the
estimation of the co-distribution of P. falciparum and hookworm and the school-age
populations at risk of coincident infection.6 Here we extend this approach to quantify the
populations at risk of infection with both P. falciparum and each of the major STH species.
In areas of stable endemic malaria transmission between 17.8-32.1 million children aged
5-14 years are estimated to be at risk of co-infection with P. falciparum and different STH
species, with the risk greatest for hookworm (Table 1). Between 5.8-9.6 million and 1.6-3.4
million children at risk of co-infection in areas of acute marginal seasonal transmission and
marginal transmission, respectively. This analysis indicates that the coincidental malaria-
STH at-risk population is greatest for hookworm than either A. lumbricoides or T. trichiura.
Schistosomiasis has a more focal distribution due to spatial heterogeneities in snail
dynamics and human behaviour3, making the prediction of co-distribution with malaria
more difficult to assess. Finally, many of the areas endemic for LF and onchocerciasis are
also affected by malaria,19 although this remains to be reliably quantified.
EPIDEMIOLOGY OF CO-INFECTION
Patterns of single parasite species infection of STH or P. falciparum have been well
documented during classical epidemiology. Both types of parasites exhibit marked age-
dependency in infection patterns. Age-stratified epidemiological studies indicate that the
prevalence of asymptomatic Plasmodium infections increases in early childhood, beginning
to decline with the gradual acquisition of immunity. The precise rate and age at which
immunity is acquired is exposure dependent, but in areas of stable transmission infections in
adulthood are generally low (Figure 1). In contrast, the prevalence of STH and
schistosomiasis infections increases throughout childhood to a relatively stable plateau or
show a slight decrease in adulthood. The highest prevalence of LF generally occurs during
adulthood, though there has been increasing appreciation of LF as an important public health
problem among children and adolescents.20 In contrast to such characteristic age
dependency, age-specific patterns of O.volvulus show strong variation according to
locatities.21
Helminths have an over-dispersed distribution, with most individuals harbouring few or no
worms and the majority of the worm population found in a minority of individuals 22; it is
within this group that most of the morbidity occurs. Similar patterns of over-dispersion are
also evident for P. falciparium infections: recent modelling of parasite prevalence and the
basic reproduction rate of infection suggests that 20% of children in a community receive
80% of new infections in a community.23 Both malaria and helminth infections have a
tendency to cluster within certain families and households.24, 25
In contrast to the well-characterised patterns of single parasite infections, we know
surprisingly little about the patterns and risk factors of co-infection within communities. The
occurrence of co-infection will depend on (i) the overall prevalence of individual species
and (ii) the degree of association between different species. If infection with P. falciparum
and helminths are independent then occurrence of co-infection is simply determined by the
relative frequency of individual species. Thus, the age patterns of co-infection will depend
on the age-specific prevalence rates as predicted by simple probability. However, if co-
infection is either synergistic or antagonistic then occurrence of both parasites would be
significantly different from that predicted by individual chance encounters with either
infection. Such associations may arise due to biological associations, whereby the presence
of one species promotes or inhibits the establishment and/or survival of the second species,
potentially through immune modulation.8 Alternatively, co-infection may reflect
concurrence of common socio-economic and/or environmental risk factors promoting
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survival of both species.15, 26 At present, there are too few studies able to disentangle the
relative importance of different risk factors for co-infection and detailed epidemiological
studies are clearly warranted.
However, on what we currently know about the epidemiology of co-infection, it is suggested
that school-age children, rather than pre-school children or adults, are most at-risk of
plasmodium-helminth co-infection (Figure 1), and thereby at greatest risk of the
consequences of co-infection. The next section provides a brief review of the immunological
consequences of co-infection, before turning to the impact of co-infection on hemoglobin
levels.
IMMUNE CONSEQUENCES OF CO-INFECTION
The successful resolution of Plasmodium infection requires a coordinated succession from a
T-helper cell type 1 (Th1) to a Th2 type response, and anything that upsets the timing or
balance of this process can lead to chronic or severe infection.27 The Th2-skewed immune
profile and profound cellular hyporesponsiveness induced by chronic helminth infection7
might therefore be expected to affect the course of Plasmodium infection. This hypothesis
has led researchers to investigate the interactions between Plasmodium and helminth
infection. However, limited observational studies so far have provided conflicting accounts
of the effects of chronic helminth infection on host immune responses to malaria. Early
studies suggested that Ascaris lumbricoides infection might be protective against malarial
disease,28, 29 in contrast to several later reports, which suggested that STH infections may
increase the risk of malaria infection. 26, 30-33 Conversely, a potential protective effect on
malaria of light schistosome infection has been reported in Senegal and Mali.34, 35 Other
studies have noted a difference in the development of severe malaria between helminth-
infected and uninfected individuals, with several studies from Thailand suggesting a
protective effect for A. lumbricoides infection on the risk of cerebral malaria and acute renal
failure,36-39 although again this is in contrast to a study in Senegal, which suggested a
positive association between infection with A. lumbricoides and the occurrence of severe
malaria.33 Thus, epidemiological observations now suggest a range of scenarios in which
helminth infections may increase susceptibility to Plasmodium infection but may also under
certain circumstances protect against severe malaria.8 The potential immuno-regulatory
mechanisms by which helminths may alter immune responses to malaria are summarized in
Figure 2. Despite the biological plausibility of synergism and antagonistism and the
somewhat contradictory evidence15, the precise relationship between co-infection and
clinical malaria continues to remain difficult to empirically determine, and definitive studies
are urgently needed to resolve the issue.
Figure 2 also illustrates the possible mechanisms by which malaria and helminths may cause
anemia. The next section expands on these mechanisms and assesses the epidemiological
evidence on the potential impact of co-infection on hemoglobin levels.
IMPACT OF CO-INFECTION ON ANEMIA
Anemia is one of the most widespread and common health condition afflicting individuals
living in the tropics, and in Africa contributes to 23% of nutrition-related disability-adjusted
life years.40 The consequences of anemia are particularly severe for children and pregnant
women.12, 41 Chronic anemia during childhood is associated with impairments in physical
growth, cognition and school performance,42 while severe anemia accounts for up to half of
the malaria attributable deaths in children under five. 43, 44 Maternal anemia is associated
with low birth weight and increased maternal morbidity and mortality.38 While the etiology
of anemia is complex and multi-factorial in origin, parasitic diseases, including P.
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falciparum and helminth infections, have long been recognised as major contributors to
anemia in endemic countries.
Recent meta-analyses of malaria intervention trials among African children provide
compelling evidence that both symptomatic and asymptomatic malaria contributes
substantially to anemia inendemic regions.43, 45 Malaria contributes to reduce hemoglobin
concentrations through a number of mechanisms, principally by destruction and removal of
parasitized red cells and the shortening of the life span of non-parasitized red cells, and
decreasing the rate of erythrocyte production in the bone marrow.46 Some of the
mechanisms that cause anemia during malaria are associated more with the acute clinical
states (e.g. hemolysis or cytokine disturbances), whereas chronic or repeated infections are
more likely to involve dyserythropoiesis.9 Data among Ghanaian schoolchildren suggest
that hemoglobin concentration was 9 g/L lower among children with asymptomatic P.
falciparum infection than children uninfected.47 Although this finding cannot be
extrapolated to all settings, these results suggest that asymptomatic parasitaemia may be
associated with a marked reduction in hemoglobin concentration among older children who
are also at highest risk of helminth infection.
The effects of infection with a single helminth species on the risk of anemia are well
documented, with risk correlated with infection intensity. 11, 48, 49 A recent study among
Filipino schoolchildren highlights how even low-intensity multiple helminth infections
enhance anaemia risk.50 Hookworm causes iron deficiency anemia through the process of
intestinal blood loss.10 Schistomes also cause anemia by chronic blood loss, as eggs
penetrate the wall of the bowl (in intestinal schistosomiasis) and the urinary tract (in urinary
schistosomiasis).11 Like malaria, anemia due to schistosomes can additionally arise from
destruction of red blood cells and/or dyserythropoiesis. Ascaris lumbricoides and Trichuris
trichuria typically have little impact on iron status.51
Based on the distinct mechanisms by which malaria and hookworm and schistosomes reduce
hemoglobin levels, it can be speculated that their combined presence might interact to
enhance the risk of anemia. However, little is known about the impact of co-infection on
anemia among different age groups. We have approached this paucity of data by re-
analysing available data from Kenya to investigate the association between co-infection and
hemoglobin levels (Figure 3). Data for pre-school children indicate that co-infection with P.
falciparum and heavy hookworm is associated with significantly lower hemoglobin
concentration than single infections with either P. falciparum or hookworm (Figure 4a).
Among schoolchildren, hemoglobin is 4.2 g/L (95% CI: 3.1-5.2 g/L) lower among children
harbouring co-infections than single species infections (Figure 4b). In contrast, no
significant difference was observed among pregnant women; although both malaria and
hookworm alone had a significant impact on hemoglobin levels (Figure 4c). Although these
data are suggestive of an additive impact of co-infection on anemia in certain age groups, it
should be noted that such associations may be confounded by socio-economic, genetic and
nutritional factors, and that the effects of co-infection may vary by malaria and helminth
transmission intensities.52 Consequently, randomized controlled trials of combining
malaria- and helminth-specific interventions aimed at establishing the contribution of co-
infection on anemia should be conducted in a range of transmission settings.
In the absence of further data on the effects of co-infection on anemia, the significance of
these re-analysed data must be treated with caution but should not be ignored either.
Overlooking the impact of co-infection may underestimate the disease burden of malaria.
For young children, co-infection may be relatively unimportant since, although the impact of
co-infection on hemoglobin levels is extremely marked, co-infection occurs relatively
infrequently (only 3.5% of pre-schoolers harboured both heavy hookworm and P. falciparum
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infection). Among school-age children the picture appears different however: 35.2% of
school-age children in the Kenyan study harboured both heavy hookworm and P. falciparum
infection. On the assumptions that these data are representative, the impact of co-infection
on anemia may be associated with a significant disease burden among African school-age
children in areas of high parasite transmission. In numerical terms, up to 32 million African
school-age children in areas of stable malaria transmission may be at risk of heavy
hookworm and P. falciparum infection, and thus at enhanced risk of anemia. 6 The situation
in settings with low parasite transmission or adequate nutritional intake is currently
unknown and merits exploration. The next section discusses potential approaches to
combining malaria and helminth interventions aimed at reducing the anemia-related disease
burden associated with co-infection.
COMBINED CONTROL
Several effective malaria control interventions currently exist, including residual house
spraying, insecticide-impregnated materials (particularly bed nets), and antimalarial drugs.
Increasing political and financial support for malaria control, as well as renewed emphasis
on population-based anthelmintic treatment,14 makes a combined malaria-helminth
approach to control timely. Although the appropriateness of different intervention strategies
will depend on a complex of interacting factors that determine the epidemiology of infection
and availability of delivery mechanisms, there exist multiple potential for combining malaria
control with helminth control (Table 2).
Infants and pre-school children
While early diagnosis and prompt treatment is a vital element of malaria control,53
chemoprophylaxis and insecticide-treated nets (ITNs) have been shown to be highly
effective at reducing malaria-related mortality and morbidity.54-56 A promising new
alternative malaria control strategy is intermittent preventive treatment in infants (IPTi).57
Here, treatment doses of sulphadoxine/pyrimethamine (SP) are delivered to infants,
irrespective of infection status, at the time of routine vaccination during the first year of life.
Additionally, studies in west Africa have demonstrated that seasonal IPT could be an
effective malaria prevention strategy among children under five years of age in areas of
seasonal malaria transmission,58, 59 but further investigation is required to determine
whether this is a practical approach to malaria control.60, 61 In terms of the impact of IPTi
on anemia, a trial among Tanzania infants found a 50% protective efficacy against severe
anemia.62 Among Ghanaian infants, IPTi was associated with a significantly higher mean
packed cell volume at 12 months of age, but was associated with slightly lower volumes at
18 months.63
Regarding helminth control among pre-school children, the benefits of deworming are
increasingly appreciated. For example, recent evidence from Zanzibar indicates that
anthelmintic treatment significantly reduced the prevalence of anemia and stunting among
pre-schoolers who received mebendazole every three months for a year.64 On the basis of
available evidence on the effectiveness of treatment and the safety of providing to young
children, WHO now recommends in areas of high helminth prevalence to provide
anthelmintic treatment to children from the age of 12 months.65, 66 Thus, anthelmintic
treatment could potentially be co-administered with IPT to children aged one to five years in
areas of seasonal malaria transmission. Based on current guidelines, deworming is unable to
be provided as part of IPTi activities.
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School-age children
The delivery of malaria chemoprophylaxis to schoolchildren through schools was
widespread in Africa during the 1950's and 1960's, and resulted in significant reductions in
parasitaemia and rates of anemia and clinical malaria attacks.45, 67 However, regular
chemoprophylaxis in malaria-endemic countries proved to be unsustainable, largely due to
problems in drug distribution and financing and concerns about the potential emergence of
drug resistance.68 Today there is a renewed interest in the potential of the education sector
to address the impact of malaria on school-age children.69, 70 A recent study of the impact
of insecticide (permethrin)-treated bed nets (ITNs) on the health of adolescent schoolgirls in
western Kenya found that ITNs were associated with an increase in hemoglobin
concentrations (0.34 g/dL (95% CI = 0.02, 0.66)).71 A study in Tanzania demonstrates the
effectiveness of teachers in recognizing and treating malaria in school children,72 and a
study in Malawi demonstrated the effectiveness of presumptive treatment in reducing
malaria-related mortality among schoolchildren where teachers were trained to use “first aid
kits” to dispense SP treatment to symptomatic children.73
IPT may also prove a valuable approach in older children in preventing malaria-related
anemia. A trial was recently completed among schoolchildren in a high malaria transmission
area of western Kenya evaluating the effect of IPT using SP combined with amodiaquine on
children's hemoglobin concentrations and their ability to concentrate in class, whereby
children were provided with a curative treatment dose every term during the school year,
regardless of infection. Preliminary results indicate that IPT almost halves (protective
efficacy 55%, 95% confidence interval [CI]: 20-74%) the occurrence of anaemia and
reduces malaria parasitaemia by 90% (95% CI: 82-95%) (Clarke and others, unpublished
data). Future work will address the effectiveness of the approach in a range of transmission
settings and the operational feasibility of integrating the approach into current school health
programs, including provision of IPT by teachers.
In contrast to the operational uncertainties and absence of guidance as to good practice for
malaria control in schools, global efforts are already underway to control helminth-related
morbidity among school-age children through the combined delivery of praziquantel to treat
schistosomiasis and benzimidazole anthelmintics, albdendazole and mebendazole, to treat
STH infections. Because the most intense helminth infections and related illnesses occur at
school age 74, 75 and infection can have adverse consequences for health and development,
76 many of which is rapidly reversed by treatment, school age children are the natural
targets for treatment. In addition, school-based treatment delivery programs offer several
cost advantages because of the use of the existing school infrastructure and the fact that
schoolchildren are accessible through schools.77
Thus, school-based deworming programmes may provide a possible entry point for
combined delivery of IPT and anthelmintics, or at least a way of sharing resources to do so,
with limited increase in operational costs. Combined school-based parasite control is not
new, however, and many useful lessons can be learned from past experiences.78 Health
promotion activities and teaching within schools to encourage good hygiene practices and
awareness of malaria prevention methods, such as the use of sleeping under an insecticide-
treated net, will help support and maintain health gains.
Pregnant women
The current recommended control strategy for malaria during pregnancy in areas of stable
transmission is IPT with SP, given during the second and third trimester,66 which provides
benefits in terms of reduced rates of maternal anemia 79 and malaria morbidity.80, 81 The
use of ITNs, which have a well-documented beneficial impact on pregnancy outcomes,82 is
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also advocated. Although screening and treatment for hookworm infection in pregnant
women is recommended,83 there are surprisingly very few published studies reporting the
impact of deworming on maternal health or pregnancy in Africa. Trials among pregnant
women in Sierra Leone84 and in Peru85 show that deworming resulted in increased
hemoglobin concentrations, and a study in Nepal found that deworming resulted in
improvements in maternal iron status, birth weight and perinatal survival.86 Further
investigation of the benefits of deworming among African pregnant women is clearly
needed. Although co-infection was not found to be associated with lower hemoglobin
among Kenyan pregnant women (Figure 4c), the detrimental effects of malaria and
hookworm alone – together with the potential impact of schistosomiasis in pregnancy87 –
warrants the evaluation of the combined use of IPT with SP and anthelmintic treatment. The
potential additive benefits of combining interventions targeted at anemia is illustrated by a
study in Sri Lanka which showed that mebendazole given in combination with iron-folate
can improve hemoglobin and iron status more than iron-folate alone.88
Community-based control
ITN distribution and residual house spraying are the main community-based malaria control
strategies. In the more rural areas Africa, the same Anopheles mosquito species transmit
both LF and malaria; in most urban and semi-urban areas, Culex spp. mosquitoes are the
major vectors for W. bancrofti. Pilot studies indicate that ITNs can impact on vector biting
densities of both Anopheles spp. and Cx. quinquefasciatus and on overall transmission of W.
bancrofti.89, 90 For this reason, it has been suggested that the global LF programmes lends
itself particularly well to linkage with malaria control programmes in areas co-endemic for
LF and malaria.19
The cornerstone of onchocerciasis control is larviciding of Simulium (blackfly) vector
breeding grounds and mass drug administration with ivermectin.5, 91 Since 1995, the
African Programme for Onchocerciasis Control has implemented community-directed
treatment (CDT) with ivermectin, whereby communities themselves appoints local drug
distributors.91CDT has also been a feature of the Global Programme to Eliminate LF,
whereby communities are treated with albendazole and ivermectin in areas where
onchocerciasis is endemic and albendazole and diethylcarbamazine (DEC) elsewhere.92 The
CDT strategy is increasingly being used as platform to combining other community-based
health interventions, including malaria interventions.19 Such linkage can help maintain high
coverage levels achieved through onchocerciasis and LF CDT-based control. For example,
recent experience in Nigeria suggests that integrated distribution by community volunteers
of anthelmintics against LF and onchocerciasis, as well as ITNs, resulted in an increased net
uptake.93 These observations provide early indication of the feasibility of ITN distribution
through a mass treatment campaign for helminths.
PROPOSED RESEARCH AGENDA
If there was a move toward a combined strategy to malaria-helminth control there is a need
to broaden the scope of research. Clearly the epidemiology of co-infection must be better
studied before appropriate recommendations for the appropriate epidemiological setting can
be made. The relevance of different parasite-specific interventions will vary according to
different transmission intensity conditions.94 For example, IPTi may only be appropriate in
areas of stable or seasonal malaria transmission, but not areas of low transmission.
Moreover, whether iron supplementation should be withheld in young children is crucially
dependent on understanding of the relative risk of iron deficiency and the rate of exposure to
malaria, such that recommendations for iron supplementation cannot be based on a limited
number of studies but need to be tailored to the nutritional status of the population and the
intensity of malaria transmission.95 Finally, the impact of different mixes of interventions
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may depend on the intensity of malaria and helminth transmission – a single approach to
combined control is highly unlikely. To guide rational control a number of key issues need
to be empirically investigated in a range of transmission and operational settings. As a first
effort, we propose the investigation of the following key areas.
First, to better define the consequences of co-infection related anemia requires more detailed
analysis of empirical data on hemoglobin concentrations among different population groups
to investigate the relationship between malaria-helminth co-infection on hemoglobin and
iron deficiency anemia. The recently launched studies of IPT can potentially be combined
with deworming to provide a more powerful platform to quantity the consequences of co-
infection on anemia more precisely. There is also a clear need to look at mechanisms of this
process when confronted with a co-infected individual. Therefore measurements of intestinal
blood (fecal protoporphyrin), shortened RBC half life, iron binding capacity, splenic
sequestration, dyserthyropoiesis should be examined in the polyparasitized, it may be more
than additive. Such work is important to better define the contribution of co-infection to
public health burden in Africa and would also allow for a realistic framework to understand
how to target intervention needs, as well as, provide a rubric against which to measure
progress toward national and international public health goals.
Second, to help identify priority areas for combined control, there is a requirement to
delineate and understand the spatial overlap and co-endemicity of malaria-helminth
infections. Mapping of malaria has undergone a renaissance following an increased
recognition that malaria interventions such as IPTi and vector control approaches must be
guided by effective cartography of malaria endemicity risk.94 In addition, the value of a
geographical perspective to helminth epidemiology and control has long been recognized,
and has been supported by the recent use of GIS and remote sensing.2, 3, 96 Geographical
congruency of different parasite species can be based initially on climate-based disease risk
maps, such as those presented here used to model plasmodium-STH co-distribution.6 Such
maps, however, however, belie the geographical variation evident at the community level
which is difficult to capture with existing risk models, and there is a requirement for more
detailed empirical data collected through structured field surveys. For example, in light of
recent evidence suggestive of a negative spatial association between W. bancrofti and P.
falciparum in west Africa,97 the distribution of LF and malaria at local scales urgently needs
to be better determined. Moreover, it remains unclear how patterns of co-distribution
actually relate to co-infection, and how distributions of co-infection vary with environmental
and socio-economic heterogeneities. Interpretation of future survey data would, in turn, be
facilitated by geostatistical models which will help to identify significant spatial risk factors
and predict patterns of co-endemicity and co-infection. To date, only one study has
attempted to model the spatial occurrence of co-infection,98 and it showed that it was
possible to predict spatial patterns of S. mansoni and hookworm. An improved
understanding of spatial risk factors will allow the projection of co-endemicity on the basis
of remotely sensed satellite data to allow for improved co-infection disease burden
estimates. Newly refined endemicity maps will provide the basis for rational implementation
of combined control by deriving more-accurate commodity and budget estimates for
different intervention types and mixes within countries.
Third, because the mix of optimal interventions will depend of the level of parasite
transmission, there is a need to determine the cost-effectiveness of different intervention
combinations in a range of endemicity conditions. An anticipated benefit of combining
malaria and helminth control in Africa would be the health gains that could result from
reducing anemia. As indicated, possible options include the linkage of IPTp with deworming
to tackle maternal anemia and the combined delivery of IPT and deworming through schools
to improve hemoglobin levels. In addition to these immediate health impacts, they may also
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be benefits on, often neglected, non-health benefits including cognition and school
performance.
Combining different interventions may yield what economists call economies of scope,
thereby resulting in lower average costs.99 However, this may also cause diseconomies of
scope (increasing average costs), whereby adding more treatments overloads capacity and
the current intervention is delivered less efficiently.100 This aspect deserves critical
attention as integrated programmes are rolled out. There are also a number of operational
research questions that would require attention, including optimising delivery systems,
identifying appropriate drug combinations, devising appropriate monitoring and evaluation.
Finally, the safety of different IPT and anthelmintic drug combinations needs to firmly
established before interventions can be rolled out.
CONCLUSIONS
Early hypotheses on malaria-helminth interactions arose from studies documenting the
potent immune responses evoked by helminths and the Th1/Th2 hypothesis. More recent
attention has focused on the potential impact of co-infection on hemoglobin levels and the
relevance of an integrated approach to controlling childhood anemia. However, the
epidemiological evidence base on co-infection is currently inadequate, and there is a need to
adopt a credible, data-driven approach to resolve key scientific and programmatic questions.
We have presented preliminary analysis of available data to investigate issues, but it is clear
that further detailed study in a range of parasite transmission settings is warranted. We
would argue that co-infection and its impact on anemia should be investigated in the same
rigorous way that single parasite species has been investigated, thereby allowing the
development of a realistic framework to prioritize resources and to anticipate potential
intervention impact. Several opportunities for combining malaria control with anthelmintic
treatment currently exist, and we would suggest that combined intervention would be
particularly relevant for vulnerable populations who are at the highest risk for anemia such
as children and pregnant women. However, relevant interventions should be tailored to the
epidemiological conditions so that resources are optimally targeted.
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FIGURE 1.
Typical age profiles of prevalence P. falciparum infection, hookworm and S. mansoni. Data
taken from Ashford et al. 103 and Kabatereine et al. 104
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FIGURE 2.
Plasmodium-helminth co-infection: hypothesised mechanisms through which helminths may
alter the risk of malarial infection and disease, and the mechanisms through which anemia
arises. Chronic helminth infection induces a T-helper 2 (Th2) cytokine response, which may
impose cross-regulatory effects on the development of an appropriate pro-inflammatory
response to initial malaria infection,105-108 and skew anti-plasmodium antibody responses
towards the production of non-cytophilic immunoglobulins ineffective against malaria (IgG4
and IgGM), instead of cytophilic ones necessary for immunity (IgG1 and IgG3).109, 110
However, induction of an anti-inflammatory immunosuppressive network may in fact
prevent severe pathology in the later stages of malaria infection, with high levels of
helminth-induced interleukin(IL)-10 111-114 acting to down-module the effects of
interferon (IFN)-γ and tumor necrosis factor (TNF)-α, thus reducing malaria pathology.8
Alternatively sequestration of infected red blood cells may be prevented through IgE-
mediated activation of the CD23/NO pathway.115 Adapted and expanded from Hartgers and
Yazdanbakhsh.8
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FIGURE 3.
The relationship between plasmodia-hookworm co-infection and mean hemoglobin
concentration in Kenya based on re-analysis of published data. (a) Pre-school children: 460
children among whom 61.5% were uninfected; 30.9% infected with P. falciparum alone;
4.1% with heavy hookworm (eggs/gram feces (epg)>2000); and 3.5% with both, based on
Brooker et al.116 (b) School-age children: 392 children among whom 19.1% were
uninfected; 27.8% infected with P. falciparum alone; 17.9% with heavy hookworm (eggs/
gram feces (epg)>2000); and 35.2% with both, based on Stephenson et al. (1985).48 (c)
Pregnant women: 251 women among whom 68.5% were uninfected; 21.1% infected with P.
falciparum alone; 6.0% with heavy hookworm (eggs/gram feces (epg)>2000); and 4.4%
with both, based on Shulman et al. 117. Mean hemoglobin based on regression modelling
adjusting for age and sex, and nutrition and socio-economic status (pre-school children) and
gestation (pregnant women). Error bars indicates 95% confidence intervals.
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Table 1
School-aged population (millions) at risk in 2005 of co-infection of Plasmodium falciparum and soil-
transmitted helminth (STH) infection. Analysis extended from Ref 5.
STHa and P. falciparumb risk African school-age population (millions) exposed to
risk of co-infection
A. lumbricoides
Stable endemic 17.87 (17.44-18.29)c
Acute seasonal 5.76 (5.59-5.92)
Marginal 1.61 (1.56-1.66)
T. trichuria
Stable endemic 21.59 (21.21-21.97)
Acute seasonal 6.99 (6.85-7.14)
Marginal 1.75 (1.70-1.79)
Hookworm
Stable endemic 32.05 (31.44-32.67)
Acute seasonal 9.55 (9.34-9.78)
Marginal 3.36 (3.18-3.52)
a
Predicted prevalence of STH based on species-specific models of the relationships between observed prevalence of infection among school-aged
children for 1172 sites across sub-Saharan Africa and satellite-derived environmental data (temperature and vegetation) and elevation data. All
surveys were conducted using similar diagnostic techniques (direct smear, typically using the Kato-Katz method) and based on random samples of
children in areas where no control measures have previously been undertaken. For further details, see Brooker et al.2
b
Based on a climate-driven model of malaria suitability which has previously been used to classify populations exposed to risk of stable malaria
and epidemic malaria (Craig et al., 1999). This model provides Fuzzy Climate Suitability (FCS) values, ranging from unsuitable [0] to completely
suitable [1] for stable P. falciparum transmission. We adopted a modified classification of this risk criteria used in previous estimations of
childhood populations at risk of different transmission conditions17, 18: zero risk [FCS = 0], marginal risk [FCS >0-<0.25], acute seasonal
transmission [FCS >0.25-<0.75] and stable endemic transmission [FCS >0.75]. The FCS risk classes were additionally adjusted for the suppressive
effects of urbanization on malaria transmission using the approach developed by Hay et al. 17
c
Populations at risk based on projected 2005 school-age population estimates which were abstracted from the Gridded Population of the World
version 3.0101 and country-specific medium variant population growth rates and proportions of the population aged 5-14 years from the United
Nations Population Division – World Population Prospects database.102 The combined STH- and malaria-risk and population models were used to
estimate the populations at risk of co-infection. To estimate the combined risk of STH and P. falciparum, independence between species was
assumed. Ninety-five percent confidence intervals are based on those calculated for the predicted STH prevalence. For further details, see Brooker
et al.6
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Table 2
Potential malaria and helminth control strategies which could be combined. Expanded from Ref19
Population Malaria STH and schistosomiasis Lymphatic filariasis Onchocerciasis
Infants and pre-
school children
IPTi/IPTca
ITNs
Regular treatment with ABZ & PQZb NRc NRc
School-age
children
IPT in schoolsa
Health education to promote ITN
use and prompt effective treatment
Regular treatment with ABZ & PQZ
Health education on prevention
Improved sanitation
Pregnant women IPTp
ITNs
Regular treatment with ABZ & PQZd
Community-based
control
ITNs
Health education to promote ITN
use and prompt effective treatment
Regular treatment with ABZ & PQZ
Health education on prevention
Improved sanitation
Annual CDT with ABZ
plus IVMe or with ABZ
plus DECf
Vector control where
appropriate
CDT treatment with IVM
Vector control where
appropriate
IPTi = Intermittent Preventive Treatment in infants; IPTc = Intermittent Preventive Treatment in young children; IPTp = Intermittent Preventive
Treatment in pregnancy; ITNs = Insecticide Treatment Nets; ABZ = Albendazole; PQZ = Praziquantel; CDT = Community-directed treatment;
IVM = Ivermectin; DEC = Diethylcarbamazine.
aNot yet recommended by WHO and is the subject of ongoing evaluation
b
To children aged one year and above
cNot recommended
d
In second and third trimester of pregnancy
e
In areas co-endemic with onchocerciasis
f
In non-endemic onchocerciasis areas
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